Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Sci ; 97(9): 889-95, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16776778

ABSTRACT

CD47 is an integrin-associated penta-transmembrane protein that possesses an immunoglobulin-like domain in its extracellular region. We have now investigated the role of CD47 in the regulation of epithelial cell spreading and migration. CD47 is colocalized with E-cadherin at cell-cell adhesion sites of epithelial cells. A Ca2+ switch experiment showed that CD47 was endocytosed and then relocalized to cell-cell adhesion sites in a similar manner to E-cadherin. Such polarized localization of CD47 required the multiple spanning region of this protein. Forced expression of CD47 induced cell spreading with marked lamellipodium formation and resulted in both partial disruption of cell-cell adhesion and enhancement of the hepatocyte growth factor-stimulated scattering of Madin-Darby canine kidney cells. The CD47-induced cell spreading was blocked by inhibition of Src and mitogen-activated protein kinase kinase. Thus, these results suggest that CD47 participates in the regulation of cell-cell adhesion and cell migration through reorganization of the actin cytoskeleton in epithelial cells. This function of CD47 is mediated by the activation of Src and mitogen-activated protein kinase kinase.


Subject(s)
CD47 Antigen/metabolism , Cell Communication/physiology , Cell Movement/physiology , Epithelial Cells/physiology , Signal Transduction/physiology , Actins/metabolism , Actins/ultrastructure , Animals , Cell Adhesion/physiology , Cells, Cultured , Cytoskeleton/metabolism , Cytoskeleton/ultrastructure , Dogs , Epithelial Cells/ultrastructure , Fluorescent Antibody Technique , Humans , Mice , Mitogen-Activated Protein Kinases/metabolism , Pseudopodia/metabolism , Rats , Transfection , src-Family Kinases/metabolism
2.
J Dermatol ; 33(1): 55-8, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16469087

ABSTRACT

A 34-year-old woman with adult-onset Still's disease (AOSD) developed prurigo pigmentosa-like lesions on her chest and upper back in addition to the typical rash of AOSD. A biopsy specimen taken from the upper back showed characteristic features of prurigo pigmentosa. The eruption and fever subsided immediately after the administration of 40 mg/day prednisolone, but arthralgia persisted even after intravenous pulse methylprednisolone therapy in combination with immunosuppressive drugs. Various atypical skin rashes, including prurigo pigmentosa-like lesions, have been reported in association with AOSD. Therefore, one should carefully follow the clinical course of a patient in order not to overlook these atypical cutaneous manifestations of AOSD.


Subject(s)
Hyperpigmentation/etiology , Prurigo/etiology , Still's Disease, Adult-Onset/diagnosis , Adult , Back/pathology , Diagnosis, Differential , Female , Humans , Hyperpigmentation/pathology , Prednisolone/administration & dosage , Prurigo/pathology , Still's Disease, Adult-Onset/complications , Still's Disease, Adult-Onset/drug therapy , Still's Disease, Adult-Onset/pathology , Thorax/pathology
3.
J Immunol ; 174(4): 2004-11, 2005 Feb 15.
Article in English | MEDLINE | ID: mdl-15699129

ABSTRACT

Src homology 2 domain-containing protein tyrosine phosphatase (SHP) substrate-1 (SHPS-1) is a transmembrane protein that is expressed predominantly in macrophages. Its extracellular region interacts with the transmembrane ligand CD47 expressed on the surface of adjacent cells, and its cytoplasmic region binds the protein tyrosine phosphatases SHP-1 and SHP-2. Phagocytosis of IgG- or complement-opsonized RBCs by peritoneal macrophages derived from mice that express a mutant SHPS-1 protein that lacks most of the cytoplasmic region was markedly enhanced compared with that apparent with wild-type macrophages. This effect was not observed either with CD47-deficient RBCs as the phagocytic target or in the presence of blocking Abs to SHPS-1. Depletion of SHPS-1 from wild-type macrophages by RNA interference also promoted FcgammaR-mediated phagocytosis of wild-type RBCs. Ligation of SHPS-1 on macrophages by CD47 on RBCs promoted tyrosine phosphorylation of SHPS-1 and its association with SHP-1, whereas tyrosine phosphorylation of SHPS-1 was markedly reduced in response to cross-linking of FcgammaRs. Treatment with inhibitors of PI3K or of Syk, but not with those of MEK or Src family kinases, abolished the enhancement of FcgammaR-mediated phagocytosis apparent in macrophages from SHPS-1 mutant mice. In contrast, FcgammaR-mediated tyrosine phosphorylation of Syk, Cbl, or the gamma subunit of FcR was similar in macrophages from wild-type and SHPS-1 mutant mice. These results suggest that ligation of SHPS-1 on macrophages by CD47 promotes the tyrosine phosphorylation of SHPS-1 and thereby prevents the FcgammaR-mediated disruption of the SHPS-1-SHP-1 complex, resulting in inhibition of phagocytosis. The inhibition of phagocytosis by the SHPS-1-SHP-1 complex may be mediated at the level of Syk or PI3K signaling.


Subject(s)
Antigens, CD/genetics , Antigens, Differentiation/genetics , Down-Regulation/immunology , Macrophages, Peritoneal/immunology , Macrophages, Peritoneal/metabolism , Membrane Glycoproteins/genetics , Neural Cell Adhesion Molecule L1/genetics , Phagocytosis/immunology , Receptors, Immunologic/genetics , Animals , Antibodies, Blocking/pharmacology , Antibodies, Monoclonal/pharmacology , Antigens, CD/immunology , Antigens, CD/metabolism , Antigens, CD/physiology , Antigens, Differentiation/immunology , Antigens, Differentiation/metabolism , CD47 Antigen , Complement C3b/metabolism , Cross-Linking Reagents/metabolism , Down-Regulation/genetics , Enzyme Precursors/antagonists & inhibitors , Erythrocytes/immunology , Erythrocytes/metabolism , Immunoglobulin G/metabolism , Intracellular Signaling Peptides and Proteins , Macrophages, Peritoneal/enzymology , Membrane Glycoproteins/antagonists & inhibitors , Membrane Glycoproteins/immunology , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Neural Cell Adhesion Molecule L1/antagonists & inhibitors , Neural Cell Adhesion Molecule L1/immunology , Neural Cell Adhesion Molecule L1/metabolism , Opsonin Proteins/metabolism , Phagocytosis/genetics , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation , Protein-Tyrosine Kinases/antagonists & inhibitors , RNA, Small Interfering/pharmacology , Receptors, IgG/metabolism , Receptors, IgG/physiology , Receptors, Immunologic/antagonists & inhibitors , Receptors, Immunologic/immunology , Receptors, Immunologic/metabolism , Signal Transduction/genetics , Signal Transduction/immunology , Syk Kinase , Tyrosine/metabolism , src-Family Kinases/antagonists & inhibitors
4.
J Invest Dermatol ; 120(5): 781-3, 2003 May.
Article in English | MEDLINE | ID: mdl-12713581

ABSTRACT

Type 2 oculocutaneous albinism (OCA2) is an autosomal recessive disorder that results from mutations in the P gene that codes one of the melanosomal proteins, the function of which remains unknown. In this paper, we report the frequency of OCA2, 8%, among the Japanese albino population, six novel mutations containing four missense substitutions (P198L, P211L, R10W, M398I), and two splice site mutations (IVS15+1 G>A, IVS24-1 G>C). One of them, R10W, was within the putative signal peptide at the N-terminal of the P protein. This is the first report on the frequency of OCA2 in the Japanese albino population.


Subject(s)
Albinism, Oculocutaneous/genetics , Albinism/genetics , Carrier Proteins/genetics , Membrane Proteins/genetics , Membrane Transport Proteins , Mutation , Adult , Albinism, Oculocutaneous/epidemiology , Humans , Japan , Male , Mutation, Missense , Phenotype , Polymorphism, Genetic , Polymorphism, Single-Stranded Conformational , Protein Sorting Signals
SELECTION OF CITATIONS
SEARCH DETAIL
...